Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 8/20 | 0.62 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.61 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.61 |
| ▸ | NADK | O95544 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.60 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
| ▸ | DPP4 | P27487 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6894498 | 0.89 | AHCY (0.59) | AHCYPRMT5WDR77NADKKMT2A | |
| SCHEMBL2118345 | 0.89 | AHCY (0.61) | AHCYPRMT5WDR77NADKKMT2A | |
| SCHEMBL3488655 | 0.89 | AHCY (0.62) | AHCYNADKKMT2AADORA3ADORA2A | |
| SCHEMBL397800 | 0.88 | AHCY (0.68) | AHCYPRMT5WDR77KMT2AADORA3 | |
| SCHEMBL31680251 | 0.88 | AHCY (0.68) | AHCYPRMT5WDR77KMT2AADORA3 | |
| SCHEMBL3515650 | 0.87 | PRMT5 (0.50) | AHCYPRMT5WDR77NADKKMT2A | |
| SCHEMBL21413837 | 0.87 | PRMT5 (0.64) | AHCYPRMT5WDR77KMT2AADORA3 | |
| SCHEMBL16300875 | 0.87 | PRMT5 (0.64) | AHCYPRMT5WDR77KMT2AADORA3 | |
| SCHEMBL22326787 | 0.87 | PRMT5 (0.64) | AHCYPRMT5WDR77KMT2AADORA3 | |
| SCHEMBL22326785 | 0.87 | PRMT5 (0.64) | AHCYPRMT5WDR77KMT2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 766 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144829-A1 | SYNBIOTIC COMPOSITION, METABOLITES, AND METHOD OF PREVENTING AND TREATING OBESITY-RELATED DISEASE | Hsu, Cheng-Chih (TW) | 2026-05-28 | — | — | US | claimed |
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | FRESENIUS MEDICAL CARE HOLDINGS, INC. (US) | 2026-02-19 | — | — | US | claimed |
| US-20250341515-A1 | METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | US | claimed |
| EP-4597111-A1 | USE OF METABOLIC MARKER FOR DIAGNOSIS OF LUNG CANCER STAGING AND KIT | Harbin Metanotitia Inc. (CN) | 2025-08-06 | — | — | EP | claimed |
| WO-2025085615-A1 | METHODS TO RAPIDLY DETECT METHYLTHIOADENOSINE AND RELATED METABOLITES DIRECTLY FROM PATIENT SAMPLES TO IDENTIFY 9P21 LOSS CANCERS AND TREATMENT STRATEGIES FOR PATIENTS | BAYLOR COLLEGE OF MEDICINE (US) | 2025-04-24 | — | — | WO | claimed |
| WO-2024230650-A1 | SYNBIOTIC COMPOSITION, METABOLITE AND USE THEREOF IN PREVENTION AND TREATMENT OF OBESITY-RELATED DISEASES | 徐丞志 | 2024-11-14 | — | — | WO | claimed |
| WO-2024152730-A1 | BIOMARKERS FOR IDENTIFYING INFREQUENT GOUT FLARES AND FREQUENT GOUT FLARES AND USE THEREOF | 苏州艾麦锶生命科技有限公司 | 2024-07-25 | — | — | WO | claimed |
| US-12018299-B2 | Methods and kits for quantifying adenosine-containing molecules | SEVIVO LLC (US) | 2024-06-25 | — | — | US | claimed |
| CN-116381072-B | Biomarker for identifying sporadic gout and frequent gout and application thereof | 苏州艾麦锶生命科技有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-118011003-A | Biomarker composition for diagnosing gastric cancer and application thereof | 哈尔滨脉图精准技术有限公司 | 2024-05-10 | — | — | CN | claimed |
| EP-0974362-A1 | DRUGS CONTAINING ENZYME INHIBITORS AS THE ACTIVE INGREDIENT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2000-01-26 | — | — | EP | claimed |
| EP-0869183-A1 | Genetic control of ethylene biosynthesis in plants | AGRITOPE, INC. (US) | 1998-10-07 | — | — | EP | claimed |
| EP-0505440-B1 | GENETIC CONTROL OF ETHYLENE BIOSYNTHESIS IN PLANTS | AGRITOPE INC (US) | 1998-07-22 | — | — | EP | claimed |
| US-5589623-A | TRANSFORMING PLANT CELLS WITH A VECTOR CONTAINING A DNA SEQUENCE ENCODING AN S-ADENOSYLMETHIONINE HYDROLASE ENZYME | AGRITOPE, INC. (US) | 1996-12-31 | — | — | US | claimed |
| EP-0693127-A1 | USE OF TOMATO E8-DERIVED PROMOTERS TO EXPRESS HETEROLOGOUS GENES, E.G. S-ADENOSYLMETHIONINE HYDROLASE, IN RIPENING FRUIT | EPITOPE, INC. (US) | 1996-01-24 | — | — | EP | claimed |
| US-5416250-A | Genetic control of ethylene biosynthesis in plants using S-adenosylmethionine hydrolase | AGRITOPE, INC. (US) | 1995-05-16 | — | — | US | claimed |
| WO-1994024294-A1 | USE OF TOMATO E8-DERIVED PROMOTERS TO EXPRESS HETEROLOGOUS GENES, E.G. S-ADENOSYLMETHIONINE HYDROLASE, IN RIPENING FRUIT | EPITOPE, INC. (US) | 1994-10-27 | — | — | WO | claimed |
| EP-0505440-A4 | GENETIC CONTROL OF ETHYLENE BIOSYNTHESIS IN PLANTS | — | 1992-11-19 | — | — | EP | claimed |
| EP-0505440-A1 | GENETIC CONTROL OF ETHYLENE BIOSYNTHESIS IN PLANTS | AGRITOPE, INC. (US) | 1992-09-30 | — | — | EP | claimed |
| WO-1991009112-A1 | GENETIC CONTROL OF ETHYLENE BIOSYNTHESIS IN PLANTS | AGRITOPE, INC. (US) | 1991-06-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144829-A1 | SYNBIOTIC COMPOSITION, METABOLITES, AND METHOD OF PREVENTING AND TREATING OBESITY-RELATED DISEASE | MLN, COMT, MLEC | AHCY 77/4885PRMT5 158/4885WDR77 1389/4885 |
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | SLC43A1, SLC14A1, SLC1A5 | AHCY 183/4885PRMT5 2598/4885WDR77 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.